ArticleIntestinal Failure (New York, N.Y.)
Cholestasis and hepatic dysfunction associated with parenteral nutrition in a tertiary neonatal intensive care unit (NICU): A retrospective cohort study.
Article in Intestinal Failure (New York, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Retrospective audit of neonatal intensive care unit (NICU) guidelines for evaluation of cholestasis identified a sub-group fulfilling definitions of intestinal failure and intestinal failure-associated liver disease. Material and Methods: Babies admitted to NICU between 2008 and 2022, with conjugated bilirubin ≥ 20 µmol/L and fractionated total bilirubin ≥ 20 % were identified. Infants who received prolonged parenteral nutrition (PN ≥ 30 days) were compared by presence or absence of gastrointestinal (GI) disease. Results: Of 208 infants with cholestasis, 99 (47.6 %) received prolonged PN. No GI disease was present in 39 (39.4 %). Stoma were present in 46 of 60 (76.7 %) infants with GI disease. Both groups were equally very preterm and extremely low birth weight, with no statistical difference in co-morbidities of cytomegalovirus infection, hypothyroidism, endotracheal ventilation, septicaemia, or necrotising enterocolitis. There was no statistical difference in median age at cholestasis onset (36 vs 44 days), peak bilirubin (139 vs 130 µmol/L), peak GGT (219 vs 224 IU/L), peak AST (182 vs 148 IU/L), hepatic coagulopathy (35 % vs 20.5 %) or time to normalisation of liver function tests (141 vs 112 days) between infants with or without GI disease. Infants with GI disease had greater PN exposure (median 72 vs. 40 days, p < 0.0001), development of IFALD (56.7 % vs 15.4 %, p < 0.0001) and more remained on PN at death (21.7 % vs 7.7 %, p = 0.01). No infants died from liver disease. Conclusion: Prolonged PN exposure in very premature and low birth weight babies without GI disease is associated with hepatic dysfunction comparable to equal peers with GI disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.